My Next Health Inc. (MNH) has announced its USD $400,000 in-kind support of the medical research team at the University of Regina in Canada, along with the USD $570,030 awarded from the National Football League (NFL) to investigate the use of cannabinoids, the naturally occurring compounds found in the cannabis plant, in the treatment of concussions and for pain management in football players.
Hemostemix Inc. (Hemostemix) has announced the signing of a Global Master Services Agreement with My Next Health Inc. (MNH), and has, subject to TSXV approval, obtained a subscription from MNH in the amount of USD $150,000 at CAD $0.25 per Unit.
Nurcapital Corporation Ltd. (Nurcapital), a capital pool company, and Green Sky Labs Inc. (GSL) today announced the execution of a definitive business combination agreement (the “Definitive Agreement”) which, subject to certain conditions and applicable TSX Venture Exchange (“TSXV”) approval, will result in the reverse takeover of Nurcapital by GSL and will constitute Nurcapital’s “Qualifying Transaction”, as defined by Policy 2.4 – Capital Pool Companies (“Policy 2.4”) of the TSXV (the “Proposed Qualifying Transaction”).
